Overview

Alitretinoin in the Treatment of Chronic Hand Eczema

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to investigate the safety and efficacy of alitretinoin in chronic hand eczema that is refractory to topical corticosteroids.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Basilea Pharmaceutica
Treatments:
Alitretinoin
Tretinoin
Criteria
Inclusion Criteria:

- Previous participation in therapeutic trials involving chronic hand eczema

- Relapse of chronic hand eczema, defined as 75% of the baseline initial total lesion
symptom score

Exclusion Criteria:

- Patients whose disease is adequately controlled by standard non-medicated skin care
and topical corticosteroid therapy